Novel 1,4-benzoxazine and 1,4-benzodioxine inhibitors of angiogenesis

被引:11
|
作者
Ilic, Milos [2 ]
Ilas, Janez [2 ]
Dunkel, Petra [3 ]
Matyus, Peter [3 ]
Bohac, Andrej [4 ]
Liekens, Sandra [1 ]
Kikelj, Danijel [2 ]
机构
[1] Catholic Univ Louvain, Rega Inst Med Res, B-3000 Louvain, Belgium
[2] Univ Ljubljana, Fac Pharm, SI-1000 Ljubljana, Slovenia
[3] Semmelweis Univ, Dept Organ Chem, H-1092 Budapest, Hungary
[4] Comenius Univ, Fac Nat Sci, Dept Organ Chem, Bratislava 84215, Slovakia
关键词
Angiogenesis; Thrombin; GPIIb/IIIa antagonist; Vascular endothelial growth factor; ANTITHROMBOTIC COMPOUNDS; THROMBIN; METASTASIS; GROWTH; MECHANISM; THERAPY; CANCER; PI-88; CELLS;
D O I
10.1016/j.ejmech.2012.10.001
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Esters of 1,4-benzoxazine and 1,4-benzodioxine compounds 1 and 10, which combine thrombin inhibitory and GPIIb/IIIa antagonistic activity in one molecule are shown to inhibit endothelial cell migration and tube formation in vitro and angiogenesis in the chicken chorioallantoic membrane (CAM) assay. The corresponding carboxylic acids 1 (R-2 = H) and 11 were devoid of anti-angiogenic activity, most probably due to their insufficient entry into the cell. Although thrombin inhibition remains the most probable explanation for their inhibition of angiogenesis, VEGFR2 kinase assay suggest that other targets such as VEGFR2 might be involved. (C) 2012 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:160 / 170
页数:11
相关论文
共 50 条
  • [31] Cytotoxicity of new polyfluorinated 1,4-naphtoquinones with diverse substituents in the quinone moiety
    Zakharova, Ol'ga D.
    Ovchinnikova, Ludmila P.
    Goryunov, Leonid I.
    Troshkova, Nadezhda M.
    Shteingarts, Vitalij D.
    Nevinsky, Georgy A.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (01) : 256 - 260
  • [32] The [1,2]- and [1,4]-Wittig rearrangement
    Wang, Fan
    Wang, Juhui
    Zhang, Yan
    Yang, Jingyue
    TETRAHEDRON, 2020, 76 (05)
  • [33] Synthesis and evaluation of Hsp90 inhibitors that contain the 1,4-naphthoquinone scaffold
    Hadden, M. Kyle
    Hill, Stephanie A.
    Davenport, Jason
    Matts, Robert L.
    Blagg, Brian S. J.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (02) : 634 - 640
  • [34] Syntheses and Biological Activities of 1,4-Iminoalditol Derivatives as α-L-Fucosidase Inhibitors
    Moreno-Clavijo, Elena
    Carmona, Ana T.
    Moreno-Vargas, Antonio J.
    Molina, Lidia
    Robina, Inmaculada
    CHIMIA, 2011, 65 (1-2) : 40 - 44
  • [35] Design, Synthesis and Biological Evaluation of 1,4-Benzenesulfonamide Derivatives as Glyoxalase I Inhibitors
    Audat, Suaad Abdallah
    Al-Balas, Qosay Ali
    Al-Oudat, Buthina Abdallah
    Athamneh, Mo'ad Jamil
    Bryant-Friedrich, Amanda
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 873 - 885
  • [36] Identification and Development of 1,4-Diaryl-1,2,3-triazolo-Based Ureas as Novel FLT3 Inhibitors
    Liu, Jisheng
    Wang, Yuting
    Chen, Chen
    Tu, Zhengchao
    Zhu, Sihua
    Zhou, Fengtao
    Si, Hongfei
    Zheng, Canhui
    Zhang, Zhang
    Cai, Qian
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (08): : 1567 - 1572
  • [37] 1,4-Dihydropyrazolo[4,3-d]imidazole phenyl derivatives: A novel type II Raf kinase inhibitors
    Yu, Hana
    Jung, Yunkyung
    Kim, Hwan
    Lee, Junghun
    Oh, Chang-Hyun
    Yoo, Kyung Ho
    Sim, Taebo
    Hah, Jung-Mi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (12) : 3805 - 3808
  • [38] Potent Farnesyltransferase Inhibitors with 1,4-Diazepane Scaffolds as Novel Destabilizing Microtubule Agents in Hormone-Resistant Prostate Cancer
    Wlodarczyk, Nicolas
    Le Broc-Ryckewaert, Delphine
    Gilleron, Pauline
    Lemoine, Amelie
    Farce, Amaury
    Chavatte, Philippe
    Dubois, Joelle
    Pommery, Nicole
    Henichart, Jean-Pierre
    Furman, Christophe
    Millet, Regis
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (05) : 1178 - 1190
  • [39] Reversal of multidrug resistance in cancer cells by novel asymmetrical 1,4-dihydropyridines
    Firuzi, Omidreza
    Javidnia, Katayoun
    Mansourabadi, Elham
    Saso, Luciano
    Mehdipour, Ahmad Reza
    Miri, Ramin
    ARCHIVES OF PHARMACAL RESEARCH, 2013, 36 (11) : 1392 - 1402
  • [40] Reversal of multidrug resistance in cancer cells by novel asymmetrical 1,4-dihydropyridines
    Omidreza Firuzi
    Katayoun Javidnia
    Elham Mansourabadi
    Luciano Saso
    Ahmad Reza Mehdipour
    Ramin Miri
    Archives of Pharmacal Research, 2013, 36 : 1392 - 1402